ProteoNic announces collaboration with TNO
ProteoNic announced it has entered into a collaboration with TNO to further commercialize and validate ProteoNic's UNic(tm) Expression technology in mammalian host systems. ProteoNic will provide expertise in construct design and protein expression optimization. TNO will apply this expertise and the UNic(tm) expression technology to manufacture commercial proteins in CHO cell lines.
"The use of the UNic(tm) expression enhancement technology has helped us tremendously to increase the efficiency of our protein production and has resulted in substantial cost reductions." TNO senior investigator Jan Verheijen commented. "One particular advantage was that downstream processing could remain unaltered, enabling a smooth introduction of the optimized process. The UNic(tm) technology combined with TNO's proprietary QuickZyme technology platform will give a boost to the development and manufacturing of novel protease activity assays."
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.